We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Senate report that followed an investigation by Sen. Patty Murray’s (D-Wash.) office has found that the FDA’s regulatory system for monitoring the safety of devices failed to quickly identify and resolve the spread of antibiotic-resistant infections linked to duodenoscopes. Read More
FDAnews held a webinar earlier this month in which three attorneys from Hogan Lovells, including partner Yarmela Pavlovic, explained the FDA’s direct de novo process. The following is adapted from that event. Read More
India’s medical device industry is urging the government to implement several policy measures — including tariff corrections and a new regulatory regime — to ensure the financial viability of domestic device manufacturing parks in the country. Read More